INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 158 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $1,923,000 | -76.2% | 120,278 | -56.3% | 0.00% | -78.6% |
Q4 2015 | $8,093,000 | +62.6% | 275,455 | +57.5% | 0.01% | +55.6% |
Q3 2015 | $4,977,000 | +3.2% | 174,892 | +30.3% | 0.01% | +12.5% |
Q2 2015 | $4,823,000 | +24.7% | 134,266 | +101.8% | 0.01% | +14.3% |
Q1 2015 | $3,867,000 | +108.9% | 66,524 | +19.2% | 0.01% | +133.3% |
Q3 2013 | $1,851,000 | – | 55,828 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
Front Row Advisors LLC | 60 | $0 | 0.00% |
Executive Wealth Management, LLC | 20 | $0 | 0.00% |
BARCLAYS PLC | 1,300 | $0 | 0.00% |
BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
Vectors Research Management, LLC | 505 | $0 | 0.00% |